Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Victor R Vieweg

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Psychiatry|June 29, 2002
Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugsW Victor R Vieweg
The Journal of Clinical Psychiatry|July 18, 2006
QTc and metabolic parametersW Victor R Vieweg
Circulation|July 20, 2011
Letter by Hasnain and Vieweg regarding article, "Myocardial infarction and risk of suicide: a population-based case-control study"Mehrul Hasnain, W Victor R Vieweg
The American Journal of Medicine|October 1, 2008
Acute effects of newer antipsychotic drugs on glucose metabolismMehrul Hasnain, W Victor R Vieweg
The American Journal of Medicine|October 12, 2010
Lower parasympathetic drive, insulin resistance, and depressionMehrul Hasnain, W Victor R Vieweg
Archives of Internal Medicine|December 17, 2009
Antipsychotic drug-associated acute hyperglycemia in elderly diabetic patients: do the drugs explain the hyperglycemia?Mehrul Hasnain, W Victor R Vieweg
Postgraduate Medicine|October 12, 2013
Weight considerations in psychotropic drug prescribing and switchingMehrul Hasnain, W Victor R Vieweg
Current Pharmaceutical Design|March 20, 2014
Possible role of vascular risk factors in Alzheimer's disease and vascular dementiaMehrul Hasnain, W Victor R Vieweg
The American Journal of Psychiatry|June 7, 2011
Question regarding ziprasidone and QTc interval prolongation in the ZODIAC studyW Victor R Vieweg, Mehrul Hasnain
American Heart Journal|October 12, 2010
Is screening cardiac inpatients for depression really feasible?Mehrul Hasnain, W Victor R Vieweg
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Psychiatry|June 29, 2002
Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugsW Victor R Vieweg
The Journal of Clinical Psychiatry|July 18, 2006
QTc and metabolic parametersW Victor R Vieweg
Circulation|July 20, 2011
Letter by Hasnain and Vieweg regarding article, "Myocardial infarction and risk of suicide: a population-based case-control study"Mehrul Hasnain, W Victor R Vieweg
The American Journal of Medicine|October 1, 2008
Acute effects of newer antipsychotic drugs on glucose metabolismMehrul Hasnain, W Victor R Vieweg
The American Journal of Medicine|October 12, 2010
Lower parasympathetic drive, insulin resistance, and depressionMehrul Hasnain, W Victor R Vieweg
Archives of Internal Medicine|December 17, 2009
Antipsychotic drug-associated acute hyperglycemia in elderly diabetic patients: do the drugs explain the hyperglycemia?Mehrul Hasnain, W Victor R Vieweg
Postgraduate Medicine|October 12, 2013
Weight considerations in psychotropic drug prescribing and switchingMehrul Hasnain, W Victor R Vieweg
Current Pharmaceutical Design|March 20, 2014
Possible role of vascular risk factors in Alzheimer's disease and vascular dementiaMehrul Hasnain, W Victor R Vieweg
The American Journal of Psychiatry|June 7, 2011
Question regarding ziprasidone and QTc interval prolongation in the ZODIAC studyW Victor R Vieweg, Mehrul Hasnain
American Heart Journal|October 12, 2010
Is screening cardiac inpatients for depression really feasible?Mehrul Hasnain, W Victor R Vieweg
Pageof 7